The commensal microbiota within the gastrointestinal tract is essential in maintaining homeostasis. Indeed, dysregulation in the repertoire of microbiota can result in the development of intestinal immuneinflammatory diseases. Further, this immune regulation by gut microbiota is important systemically, impacting health and disease of organ systems beyond the local environment of the gut. What has not been explored is how distant organs might in turn shape the microbiota via microbe-targeted molecules. Here, we provide evidence that surfactant protein D (SP-D) synthesized in the gallbladder and delivered into intestinal lumen binds selectively to species of gut commensal bacteria. SP-D-deficient mice manifest intestinal dysbiosis and show a susceptibility to dextran sulfate sodium-induced colitis. Further, fecal transfer from SP-D-deficient mice to wild-type, germ-free mice conveyed colitis susceptibility. Interestingly, colitis caused a notable increase in Sftpd gene expression in the gallbladder, but not in the lung, via the activity of glucocorticoids produced in the liver. These findings describe a unique mechanism of interorgan regulation of intestinal immune homeostasis by SP-D with potential clinical implications such as cholecystectomy.
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surfactant protein D | gut microbiota | gallbladder | colitis | glucocorticoids T he composition of the gut commensal microbiota reflects the coevolution of host and microorganisms to achieve intestinal homeostasis that is symbiotic or mutually beneficial (1, 2) . In this context, local interactions between commensal microbiota and intestinal cells are central to the regulation of the intestinal immune system (1, 2) . Imbalances in the microbiota, termed dysbiosis, underlie the development and/or aggravation of immune-related diseases even in distant organs from the gastrointestinal tract (1, 2) . Given the importance of this connection to human health, there has been much focus on the elucidation of the mechanisms by which the symbiosis is maintained.
One focus on this process has been the study of soluble, immunoregulatory molecules produced in the intestinal lumen by immune and epithelial cells that maintain intestinal immune homeostasis (1, 3) . However, in this context, little attention has been paid to the role of immunoregulatory molecules produced by distant organs. During the course of our study on the role of the IRF3 transcription factor in intestinal homeostasis (4), we observed the presence of surfactant protein D (SP-D) in the intestinal lumen. SP-D belongs to the collectin family of soluble innate immune receptors and is a component of lung surfactant proteins that are continuously and specifically produced in the lungs by alveolar type II epithelial cells (5) (6) (7) . Thus, SP-D protein is constitutively secreted into the alveolar fluid for the protection against aerially transmitted pathogens (5-7). SP-D binds carbohydrates, lipids, and nucleic acids with a broad spectrum of specificity (5) (6) (7) . To date, the physiological role of SP-D in other organs remains totally unknown.
In this study, we show that SP-D is produced by the gallbladder and plays a critical role in maintaining symbiotic status of the commensal bacteria. We show SP-D expression in the gallbladder epithelial cells and provide evidence that the gallbladder-produced SP-D, secreted into the bile and delivered to the intestinal lumen, is the major source of intestinal SP-D. Our results also indicate that SP-D selectively affects populations of commensal bacterial species through its direct binding to the bacteria, which interferes with their replication and causes a cascade of events that skew the repertoire of bacterial species in the intestine.
Indeed, mice deficient in the Sftpd gene (Sftpd −/− mice) show intestinal dysbiosis and sensitization to dextran sulfate sodium (DSS)-induced colitis. The importance of the dysbiosis resulting
Significance
The imbalance in the intestinal microbiota repertoire, called dysbiosis, underlies the development of inflammatory diseases in the intestine and distant organ systems. Whether and how distant organs regulate the commensal gut bacteria and intestinal homeostasis via microbe-targeted molecules has remained poorly explored. In this study, we show that the gallbladder regulates intestinal immune homeostasis through the production of surfactant protein D (SP-D) that is delivered to the intestine via bile. The importance of the gallbladder-derived SP-D was underscored by an intestinal dysbiosis in SP-D-deficient mice and susceptibility of these mice to dextran sodium sulfate sodium-induced colitis. Our study thus revealed a unique interorgan regulation of intestinal homeostasis by SP-D with potential clinical implications such as cholecystectomy.
from the absence of SP-D is further underscored by fecal transfer experiments, wherein germ-free mice receiving feces from Sftpd −/− mice are more susceptible to DSS-induced colitis compared with those that received the feces of Sftpd +/− mice. Of note, there was a significant reduction of Foxp3 expression in regulatory T cells (Tregs) in the intestinal lamina propria of Sftpd −/− mice, which may account for the increased susceptibility to colitis.
In addition, we also found a notable elevation of SP-D expression during the development of DSS-induced colitis in the gallbladder, but not in the lung. We provide evidence that colitis enhances synthesis of glucocorticoids in the liver, which is secreted into the bile to induce Sftpd mRNA expression in gallbladder epithelial cells. Taken together, our findings reveal the hitherto unknown role of SP-D in the interorgan regulation of intestinal commensal microbiota. We discuss the significance of these findings as well as the clinical implications such as cholecystectomy.
Results
Expression of SP-D in Gallbladder. When we examined relative Sftpd gene expression in various organs by quantitative RT-PCR (qRT-PCR), a notably high expression level of Sftpd mRNA was observed in the gallbladder compared with other digestive organs, including the stomach, intestines, appendix, liver, and pancreas (Fig. 1A) . Further, SP-D protein expression was detected by immunohistochemical staining in the gallbladder epithelium, but not in lamina propria (Fig. 1B) . As shown in Fig. 1C , SP-D protein was measured in the bile, suggesting that it reaches the intestinal lumen through its secretion into the bile. Consistent with this, bile duct ligation performed to inhibit bile flow into the intestine resulted in a marked reduction in SP-D protein levels in the fecal suspension (Fig. 1D ), indicating that gallbladder is the main source of SP-D found in the intestinal lumen.
Alteration of Intestinal Bacterial Population by the Absence of SP-D.
Since SP-D has been reported to play an important role in the elimination of pathogenic bacteria such as Pseudomonas aeruginosa and Staphylococcus aureus within the alveoli of the lungs (5, 7), we asked if expression of SP-D affects populations of commensal bacteria in the intestine. To address this question, we first performed a comparative microbiome analysis on feces from wild-type (WT) and Sftpd −/− mice. Interestingly, significant differences in the bacterial population and diversity were observed between WT and Sftpd −/− mice ( Fig.  1E and Fig. S1 A and B) . Since the sequence analysis of 16S ribosomal RNA (rRNA) revealed that most of the altered bacteria species have been poorly characterized, these data are presented using operational taxonomic units (OTUs) (Fig. 1F and Fig. S1C ). In this analysis, we observed that species more closely related to Clostridia cluster IV and XIVa were markedly decreased while species more closely related to the Lactobacillus salivarius cluster were increased in Sftpd −/− mice. Among the latter cluster, OTU00007 is Lactobacillus murinus as the sequence showed a similarity of 100% (8) . On the other hand, commensal fungi, which have also been implicated to be bound by SP-D (9, 10), were not detected in our specific-pathogen-free (SPF) mice, an observation similarly reported in the SPF mice (11) (Fig. S2 ).
SP-D Binding to Intestinal Bacteria and Its Effect on Bacterial Growth.
To gain further insight into the intestinal dysbiosis resulting from the absence of SP-D, we next examined SP-D binding to commensal bacteria in the feces from WT mice. For this, fecal bacteria from WT mice were stained with anti-SP-D antibody and subjected to flow cytometric analysis. As shown in Fig. 2A , commensal microbiota contained about 2% of SP-D binding bacteria and 16S rRNA sequencing further revealed that 61 OTUs were increased in SP-D-positive fraction with significant difference compared with SP-D-negative fraction (Fig. S3 ). Among them, significant SP-D binding was observed with L. murinus (OTU00007 and OTU00840) and Lactobacillus animalis (OTU01291) (Fig. 2 B and  C) , whose relative amounts were increased in Sftpd −/− mice (Fig.  S1 ), whereas such binding was not observed with OTUs closely related to Clostridia IV and XIVa (OTU00194 and OTU00272) (Fig. 2C) , which showed a decrease in these mice (Fig. S1 ). Additionally, OTU00009 (Lactobacillus johnsonii) and OTU00069 (Lactobacillus reuteri), which were unchanged in mutant mice, did not show significant binding to SP-D (Fig. 2C) .
When we next examined the effects of recombinant SP-D (rSP-D) on the growth of L. murinus in vitro, a dose-dependent inhibition was observed, suggesting that SP-D directly interferes with the growth of L. murinus in the intestine (Fig. 2D, Left) . Growth inhibition was also observed against another L. murinus strain ATCC35020 (Fig. S4A) . Of note, we found features of cell lysis of L. murinus cells incubated with rSP-D using analysis by scanning electron microscopy (Fig. S4B) . In contrast, no growth inhibition was observed for L. johnsonii, which is not bound by SP-D (Fig. 2 C  and D, Right) . In this regard, it is interesting that L. murinus interferes with the growth of the Clostridia species in vitro (Fig. S5) . (Fig.  S6) . However, the majority of Tregs in Sftpd −/− mice showed significantly lower expression levels of Foxp3 compared with Tregs from control mice (Fig. 3A) . On the other hand, no abnormality was observed in Tregs in the spleen of the mutant mice (Fig. 3B) . These data suggest that intestinal dysbiosis caused by the absence of SP-D selectively affects the development of intestinal Tregs, which are shown to be critical to the regulation of intestinal inflammatory responses (12) . Given the intestinal dysbiosis that is associated with abnormal Treg development in Sftpd −/− mice, we next examined the ability of these mice to control colonic inflammation. A model of DSSinduced colitis showed that Sftpd −/− mice had a marked increase in the susceptibility to colitis compared with WT mice as evidenced by a rapid decrease in body weight (Fig. 3C ) and shortened length of the colon (Fig. 3D) . Consistent with this, disease activity index (DAI) was significantly higher in Sftpd −/− mice (Fig. 3E ). To further examine the link between intestinal dysbiosis and aggravated colitis in Sftpd −/− mice, we next performed a fecal microbiota transplant experiment in which feces from Sftpd +/− or Sftpd −/− mice were transplanted to germ-free WT mice and then challenged with DSS. As shown in Fig. 3F , a significant loss of the body weight was observed in the mice that received the feces from Sftpd −/− mice compared with those that received feces from Sftpd +/− mice. The different phenotype observation in the germ-free mice supports the notion that, in this experimental condition, the status of microbiota remains unchanged in the germ-free mice, which have the intact Sftpd gene. These results indicate that the dysbiotic microbiota present in Sftpd −/− mice indeed accounted for the susceptibility to the colitis development, at least in part.
Interorgan Regulation of Sftpd Gene Expression in Colitis Development.
In view of the importance of gallbladder-derived SP-D to control DSS-induced colitis, we then examined whether intestinal inflammation affected Sftpd gene expression in the gallbladder. Interestingly, we found that Sftpd mRNA and SP-D protein were markedly enhanced in the gallbladder but not lungs of WT mice made to develop DSS-induced colitis ( Fig. 4A and Fig. S7A ). Since the Sftpd gene is known to be induced by fibroblast growth factors (FGFs), glucocorticoids, and endotoxin in the lung epithelial cells (13-15), we tested whether these signaling pathways could induce Sftpd mRNA in a gallbladder-derived epithelial cell line, OCUG-1. As shown in Fig. 4B and Fig. S7B , we found Sftpd mRNA is induced in a dose-dependent manner by synthetic glucocorticoids, but neither by FGFs nor LPS. Interestingly, this induction was not observed in a hepatocyte cell line Huh7 (Fig.  S7C ), suggesting the cell-type-specific Sftpd gene induction by glucocorticoids.
Consistent with this, DSS-induced colitis enhanced the concentrations of corticosterone, a major glucocorticoid in mouse, in the bile, while serum concentrations exhibited only a slight increase (Fig. 4C , Left). This was also accompanied by a significant increase in the volume of bile (Fig. 4C, Right) . Further, corticosterone levels were also increased in the liver under conditions of intestinal inflammation, but not within the gallbladder itself ( Fig.  4D ), suggesting the local production of corticosterone occurs specifically in the liver. Indeed, corticosterone levels were enhanced in the supernatants of liver tissues cultured from DSStreated mice, which was suppressed by addition to the cultures of metyrapone, an inhibitor for corticosterone-producing enzyme, Cyp11b1 (16) (Fig. 4E) . Thus, these findings suggest a feedback regulation between intestine, liver, and gallbladder in which intestinal inflammation can enhance corticosterone production by the liver that induces SP-D expression by the gallbladder, which in turn can contribute to maintain symbiotic status of commensal bacteria in the intestines.
Discussion SP-D has long been described as a surfactant protein involved in maintaining lung homeostasis (5) (6) (7) . In this study, we revealed a hitherto unknown role of SP-D in shaping microbiota in the intestines. In this model, SP-D is constitutively produced in gallbladder, but not in other digestive organs, and then delivered to the intestines where it regulates the symbiotic status of commensal bacteria. Numerous antibacterial peptides that control commensal gut microbiota via their inhibition of certain sets of bacteria have been described (1, 3) . The conventional wisdom has been that they are synthesized locally by immune or epithelial cells in the gut (1, 3) . In contrast to this view, our findings reveal a facet of intestinal microbiota regulation in which an immunoregulatory molecule, SP-D, is produced in a distant organ, i.e., gallbladder, which is then delivered to the intestine to regulate the repertoire of commensal bacteria. Although it is speculative at this stage, our study also suggests there is an additional immunoregulatory molecule(s) in the bile involved in this process.
The importance of SP-D as an interorgan mediator of immune homeostasis was underscored by intestinal dysbiosis in the Sftpd −/− mice ( Fig. 1 E and F and Fig. S1 ). In fact, our results suggest SP-D mediates the growth inhibition of commensal bacteria via a direct binding to L. murinus and related bacteria (Fig. 2) . This was further confirmed by scanning electron microscopic analysis, which showed the lysis of L. murinus in the presence of SP-D (Fig. S4B) . In this context, it is interesting that replication of two Clostridia species, whose numbers were increased in Sftpd −/− mice, was inhibited by L. murinus in a dose-dependent manner (Fig. S5) . Thus, we can offer one explanation for the dysbiosis in that SP-D inhibits replication of L. murinus, which otherwise suppresses the growth of Clostridia species. While Lactobacillus species are generally thought to be "beneficial" bacteria due to their health-promoting effects (17) (18) (19) (20) Read counts On the other hand, we did not see a strong correlation between SP-D binding to bacteria species and reduced prevalence of the bacteria in vivo (Figs. S1 and S3 ). As such, a complex cascade of events, involving interbacterial interactions and/or host-bacterial interactions, may bring about intestinal dysbiosis in the absence of SP-D. Although unlikely, it is not excluded that the absence of SP-D may also affect bile composition, thereby contributing to the intestinal dysbiosis.
The composition of commensal bacteria in the gut is known to affect development of specific immune cell subsets. This was the case for our study in which we observed alterations of lamina propria Tregs in Sftpd −/− mice. Indeed, Tregs were not significantly reduced in absolute number, but showed lower expression of Foxp3 (Fig. 3A and Fig. S6 ). Since it has been shown that an attenuated Foxp3 expression in Tregs results in a loss of immunosuppressive activity of these cells (21, 22) , exacerbation of DSS-induced colitis found in Sftpd −/− mice may be attributed, at least in part, to the abnormality of intestinal Tregs in these mice. It is interesting in this context that functional Tregs are induced by Clostridia cluster IV and XIVa species in the intestine (23) and that some of these species are reduced in Sftpd −/− mice ( Fig. 1F and Fig. S1 ). The question for how this abnormal Treg development, within the lamina propria, might contribute to the increased susceptibility to the DSS-induced colitis in Sftpd −/− mice will be an important issue to address in the future.
It is interesting that Sftpd gene expression is further enhanced by DSS-induced colitis in the gallbladder (Fig. 4A) , suggesting a feedback regulation between the intestines, liver, and gallbladder organs in response to intestinal immune inflammation. SP-D is involved in this feedback mechanism, as its expression is enhanced by glucocorticoids such as corticosterone produced by the liver and delivered to gallbladder in response to colitis (Fig. 4 B-D) . In fact, an elevation of biliary corticosterone was observed showing there is a cross-talk between these organs (Fig. 4C) . To our knowledge, glucocorticoid synthesis by the liver was previously unknown. Endotoxin and inflammatory cytokines, such as LPS, TNF-α, and IL-1β, are known to activate local corticosterone production in skin and lung (24) . We found LPS administration in the mouse indeed caused an enhancement of liver corticosterone accompanied by Sftpd mRNA expression in the gallbladder (Fig. S8) . Therefore, the enterohepatic circulation-mediated delivery of LPS and/or other inflammatory molecules produced during the development of colitis may account for the enhancement of liver corticosterone production.
At present, the physiological significance of the feedback regulation of SP-D during colitis development remains unclear. In this context, it is interesting to note that in WT mice, the number of SP-D binding bacteria is significantly increased during DSSinduced colitis (Fig. S9A) . Interestingly, however, the population of L. murinus was significantly decreased (Fig. S9B) , which is consistent with the growth inhibition of L. murinus by SP-D (Fig.  2D) . Thus, although further work will be required, a view emerges in which corticosterone-mediated induction of SP-D in the gallbladder may be important for the proper balancing of intestinal bacteria for maintaining homeostasis. Considering the critical role of SP-D in the protection of the lung against pathogens, it is possible that SP-D also plays an important role in the protection against pathogen in the gallbladder. As infection is the main cause of biliary tract inflammation such as cholecystitis and cholangitis (25) , this issue may have clinical importance to be addressed in further studies. In addition, our findings may raise a possible concern for the treatment of gallbladder-related diseases such as gallstone and gallbladder cancer. Usually, gallbladder removal or cholecystectomy is a common treatment of these diseases. Although the side effect of cholecystectomy is thought to be modest, significant change of intestinal microbiota is reported in patients treated with this procedure (26) . Therefore, our study may have clinical implication on the pathogenesis of intestinal diseases, possibly with therapeutic potential of SP-D in intestinal diseases.
Materials and Methods
Mice. FVB/Njcl (FVB) were purchased from Clea Japan, Inc. SP-D-deficient (Sftpd −/− ) mice, described previously (27) , were kindly gifted by Dr. Jeffery A. Whitsett, Cincinnati Children's Hospital Medical Center, Cincinnati, and maintained on a FVB genetic background in SPF conditions. Germ-free C57BL/6N mice were purchased from Sankyo Labo Service Corporation, Inc. or Clea Japan, Inc. All animal experiments were done in accordance with guidelines of the University of Tokyo and Osaka University. Bacteria. L. murinus (ATCC35020) was obtained from American Type Culture Collection. Clostridium 17 strain mix was described before (23) . Endogenous L. murinus and L. johnsonii were isolated from feces from SPF mice and identified by sequencing of 16S ribosomal RNA genome.
Analysis of SP-D Binding Bacteria. Fecal pellets were suspended in 1 mM CaCl 2 / PBS, weighed, and filtered by a 40-μm cell strainer. Flowthrough was washed in 1 mM CaCl 2 /PBS with 8,000 × g and left on ice for 20 min. After washing in 1% BSA/1 mM/CaCl 2 /PBS twice, it was resuspended and incubated for blocking in 2% BSA/1 mM/CaCl 2 /PBS for 20 min on ice. Bacterial concentration was adjusted by resuspending bacterial pellet from 10 mg feces in 100 μL of 2% BSA/1 mM/CaCl 2 / PBS. The 100 μL of bacterial suspension was incubated with 2 μg of anti-SP-D antibody (sd13980; Santa Cruz) or rabbit IgG for 15 min on ice. After washing with 8,000 × g at 4°C twice, bacterial suspension was resuspended in 100 μL of 2% BSA/1 mM/CaCl 2 /PBS containing 1 μg of APC-conjugated anti-rabbit IgG (sc8346; Santa Cruz) for 15 min on ice. After being washed, bacterial suspension was subjected for sorting of SP-D-positive or -negative bacteria by FACSAria cell sorter (BD).
DSS-Induced Colitis. DSS-induced colitis was performed as described before with modification (4). Age-matched animals were administered 3.5% DSS (MP Biomedicals) in drinking water for 7-9 d. For body weight change studies, the percentage of body weight was determined by the following equation: 100 × (body weight at the indicated day)/(body weight before DSS treatment). In fecal transfer experiment, 0.01 g of feces from Sftpd +/− or Sftpd −/− mice was orally inoculated into germ-free mice (C57BL/6N; Sankyo Lab). After 4 d, mice were treated with 2.5% DSS for 6 d and water for additional 2 d. DAI of DSS colitis was assessed by a previously described method (28) .
Measurement of Tissue Corticosterone. To examine tissue-contained corticosterone, tissues were homogenized in PBS (liver; 150 mg/mL, gallbladder; 1 tissue in 0.5 mL) by Shakeman3 BMS-SMN03 (Biomedical Science) and supernatants were subjected to ELISA with corticosterone ELISA kit (Enzo Life Sciences). For tissue culture, liver was sectioned into small pieces (around 3 mm square) and cultured as 100 mg tissue/mL with 199 medium (Sigma) including 5% charcoaled stripped FBS (Gibco) and 1% antibiotic-antimycotic (Gibco). After a 15-h incubation at 37°C, culture supernatants were subjected to ELISA. All other information is available in Supporting Information.
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Reagents and Cells
Dexametazone was purchased from Sigma. Human recombinant FGF7, FGF10, and EGF were purchased from R&D. OCUG1 was obtained from the Japanese Collection of Research Bioresources cell bank. Huh7 was described previously (29) . Metyrapone was purchased from Cayman. The 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor PF-915275 was purchased from Santa Cruz.
RNA Analysis
RNA was extracted by using RNeasy (Qiagen) and subjected to reverse transcription (RT) with PrimeScript RT Master Mix (TaKaRa Bio) according to the manufacturer's protocol. Quantitative RT-PCR (qRT-PCR) was performed with a LightCycle480 instrument and SYBR Green reagents (Roche Molecular Biochemicals). Data are presented as relative expression units after normalization to Gapdh. Primer sequences for Il6, Tnf, and Gapdh have been described previously (4) . Primer sequences for the Sftpd gene are as follows: Sftpd forward 5′-CCAGTTGGACC-CAAAGGAGAGAATG-3′ and Sftpd reverse 5′-GTCCTATG-TTCCCCTGCTTCCCA-3′.
Histological Analysis
Isolated gallbladders were fixed in 4% paraformaldehyde for 16 h at room temperature, embedded in paraffin, and stained with hematoxylin and eosin (H&E). Immunohistochemical analysis of SP-D was performed with mouse monoclonal anti-SP-D Ab (12G5; Abcam) or isotype mouse IgG1 (3A1; Cell Signaling) and HRP-conjugated secondary Ab to visualize signal using DAB substrate. The H&E or immunohistochemical sections were examined by microscope (Nikon ECLIPSE Ti).
ELISA for SP-D Concentration of biliary SP-D was measured by SP-D ELISA kit (Yamasa) according to the manufacturer's protocol.
Fungal DNA Analysis Fungal DNA was extracted by QIAamp DNA Stool Mini Kit (Qiagen). Primer sequences for Candida tropicalis, Saccharomycopsis fibuligera, and Saccharomyces cerevisiae have been described previously (9, 30) . Primer sequences for other microbes are as follows: Wickerhamomyces anomalus forward 5′-GCGATAAACCTTACA-CACATTGTCTA-3′ and Wickerhamomyces anomalus reverse 5′-CAGTAAGCCAGGCTCACCA-3′; Debaryomyces hansenii forward 5′-CTTGGTTGGGTTCCTCGCA-3′ and Debaryomyces hansenii reverse 5′-CGAAGTAGAGCCACATTCCTTAGT-3′; Trichosporon moniliiforme forward 5′-TTCTTAATGGCTTGGAATTGGG-TGT-3′ and Trichosporon moniliiforme reverse 5′-TTAGAAG-CGTACTTCTCAAGCCGAC-3′; Trichosporon domesticum forward 5′-AGGATCATTAGTGATTGCCTTAATTG-3′ and Trichosporon domesticum reverse 5′-ACAATGTTTGTATAAAATCGAATCCG-3′; and Trichosporonales forward 5′-GCGATAAGTAATGTGAA-TTGCAGA-3′ and Trichosporonales reverse 5′-AAGAAACCC-TAATGGTTGAGATTT-3′.
Microbiota Analysis
Bacterial DNA was extracted from the feces using the enzymatic lysis method described previously (31) . Hypervariable regions (V1-2) of 16S rRNA gene were PCR amplified using primers 27Fmod 5′-agrgtttgatymtggctcag-3′ and 338R 5′-tgctgcctcccgtaggagt-3′. The 16S metagenomic sequencing was performed according to the Illumina protocol. Two paired-end reads were merged using the fastq-join program based on overlapping sequences. Reads with an average quality value of <25 and inexact matches to both universal primer were filtered off. Filter-passed reads were used for further analysis after trimming off both primer sequences. For each sample, 10,000 quality filter-passed reads were rearranged in descending order according to the quality value and then clustered into operational taxonomic units (OTUs) with a 96% pairwise-identity cutoff using the UCLUST program (Edgar 2010) version 5.2.32 (www.drive5. com/). Taxonomic assignments of each OTU were made by similarity searching against the Ribosomal Database Project (RDP) and the National Center for Biotechnology Information genome database using the GLSEARCH program. The 16S rRNA gene V1-V2 region sequences analyzed in this study were deposited in DDBJ/GenBank/EMBL with the accession nos. BioProjectID PRJDB5950.
Bacterial Proliferation Assay
Frozen stock of L. murinus or L. johnsonii was suspended in 10 times volume of Lactobacilli MRS broth (BD Biosciences) with 2.7 mM MgCl 2 and incubated in the presence of indicated concentration of recombinant SP-D (R&D) at 37°C for indicated time periods. Relative viability of bacteria was examined by CTC assay kit (Dojindo Molecular Technologies) according to the manufacturer's protocol. OD595 was measured by microplate reader (Bio-Rad Laboratories). To examine interference of the growth of Clostridia species by L. murinus, 100 μL of confluent culture of Clostridia was diluted by 10 times with Eggerth-Gagnon (EG) broth and incubated in the absence or presence of confluent culture of L. murinus with indicated volume at 37°C under anaerobic conditions (23) . After 24 h, bacterial DNA was extracted by phenol/chloroform method and relative DNA amounts of Clostridial species were examined by qPCR with the following primers: C. bolteae forward 5′-CG-GCGTGCCTAACACAT-3′ and C. bolteae reverse 5′-GTCC-GCCACTCAGTCAATCA-3′; C. hathewayi forward 5′-CGA-GCGAAGCGGTTTCA-3′ and C. hathewayi reverse 5′-TTC-TAACTGTTATCCCCCAGTGTA-3′; and C. 7 3 54FAA forward 5′-AGTCGAACGAAGCGATTTAAC-3′ and C. 7 3 54FAA reverse 5′-CCGGAGTTTTTCACACTGTAT-3′.
Isolation of Lamina Propria Cells
The detailed protocol was previously described (32) . The procedure is briefly described as follows: After fecal content was removed, whole colonic tissue was incubated in EDTA-containing buffer to remove intestinal epithelial cells. The remaining lamina propria with muscles was cut into small pieces and digested with collagenase D, DNaseI, and dispase. After being washed, cell suspension was subjected to gradient separation to obtain lamina propria cells in the layer between upper and lower phases.
Scanning Electron Microscopy
The 1 × 10 8 cfu of L. murinus and Clostridia species were incubated with BSA (5 μg/mL) or SP-D (5 μg/mL) for 1 h in PBS (0.9 mM CaCl 2 ). Samples were placed on a plastic coverslip (Celltight C-1 Cell Desk LF; Sumitomo Bakelite Co.) and centrifuged at 700 × g for 5 min at 4°C. After several wash steps, samples were fixed with 2% formaldehyde and 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4), postfixed with 1% osmium tetroxide and 0.5% potassium ferrocyanide in the same buffer, treated with 1% tannic acid, and retreated with 1% osmium tetroxide. Samples were dehydrated in a graded series of ethanol and substituted with liquefied carbon dioxide in a chamber device, Samdri-PVT-3D (Tousimis Research Corp.). After critical point drying, samples on the coverslip were mounted on an aluminum specimen block with carbon adhesive tape and evaporated osmium tetroxide vapor. Sample cells were observed with a S-4800 field emission scanning electron microscope (Hitachi High-Technologies Corp.). 
Statistical Analysis
e d r O m u l y h P s n i a r t s d e t a l e r t s e s o l C r e b m u n T U
